| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients
|
Risi, Emanuela
|
|
2018
|
170 |
2 |
p. 329-341
|
artikel
|
| 2 |
A parallel model for breast cancer metastasis
|
Boyd, Jeff
|
|
2018
|
170 |
2 |
p. 443-444
|
artikel
|
| 3 |
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing
|
Kyker-Snowman, Kelly
|
|
2018
|
170 |
2 |
p. 425-430
|
artikel
|
| 4 |
A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients
|
Cai, Hao
|
|
2018
|
170 |
2 |
p. 271-277
|
artikel
|
| 5 |
Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011
|
Wilson, Lauren E.
|
|
2018
|
170 |
2 |
p. 361-371
|
artikel
|
| 6 |
Breast cancer survival, survival disparities, and guideline-based treatment
|
Hill, Deirdre A.
|
|
2018
|
170 |
2 |
p. 405-414
|
artikel
|
| 7 |
Breast screening and the parallel progression model of cancer
|
Autier, Philippe
|
|
2018
|
170 |
2 |
p. 439-440
|
artikel
|
| 8 |
Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
|
Turner, Tia H.
|
|
2018
|
170 |
2 |
p. 221-234
|
artikel
|
| 9 |
Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer
|
Li, Minghui
|
|
2018
|
170 |
2 |
p. 257-270
|
artikel
|
| 10 |
Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening
|
Caumo, Francesca
|
|
2018
|
170 |
2 |
p. 391-397
|
artikel
|
| 11 |
Correction to: Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
|
Erin, Nuray
|
|
2018
|
170 |
2 |
p. 251-256
|
artikel
|
| 12 |
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer
|
Bhat, Raksha R.
|
|
2018
|
170 |
2 |
p. 279-292
|
artikel
|
| 13 |
Health-related quality of life of Iranian breast cancer patients: a meta-analysis and systematic review
|
Bouya, Salehoddin
|
|
2018
|
170 |
2 |
p. 205-212
|
artikel
|
| 14 |
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
|
Agersborg, Sally
|
|
2018
|
170 |
2 |
p. 321-328
|
artikel
|
| 15 |
Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
|
Duffy, Michael J.
|
|
2018
|
170 |
2 |
p. 213-219
|
artikel
|
| 16 |
Mutational analysis of candidate genes in Israeli male breast cancer cases
|
Schayek, Hagit
|
|
2018
|
170 |
2 |
p. 399-404
|
artikel
|
| 17 |
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00
|
Munzone, Elisabetta
|
|
2018
|
170 |
2 |
p. 351-360
|
artikel
|
| 18 |
Prediction of breast cancer risk with volatile biomarkers in breath
|
Phillips, Michael
|
|
2018
|
170 |
2 |
p. 343-350
|
artikel
|
| 19 |
Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress
|
Chatterjee, Shatakshee
|
|
2018
|
170 |
2 |
p. 431-438
|
artikel
|
| 20 |
Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis
|
Thöne, Kathrin
|
|
2018
|
170 |
2 |
p. 381-390
|
artikel
|
| 21 |
Radial scar on image-guided breast biopsy: is surgical excision necessary?
|
Chou, Wendy Yen Yun
|
|
2018
|
170 |
2 |
p. 313-320
|
artikel
|
| 22 |
Receptor conversion in breast cancer patients with liver metastases after hepatectomy might affect survival
|
Altundag, Kadri
|
|
2018
|
170 |
2 |
p. 441
|
artikel
|
| 23 |
Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
|
Erin, Nuray
|
|
2018
|
170 |
2 |
p. 235-250
|
artikel
|
| 24 |
Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
|
Roy, P.
|
|
2018
|
170 |
2 |
p. 303-312
|
artikel
|
| 25 |
The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene
|
Li, Yanchun
|
|
2018
|
170 |
2 |
p. 293-302
|
artikel
|
| 26 |
Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database
|
Angarita, Fernando A.
|
|
2018
|
170 |
2 |
p. 373-379
|
artikel
|
| 27 |
Validation of a personalized risk prediction model for contralateral breast cancer
|
Chowdhury, Marzana
|
|
2018
|
170 |
2 |
p. 415-423
|
artikel
|
Tijdschrift beschrijving